349
Views
0
CrossRef citations to date
0
Altmetric
Invited Reviews

Exogenous Endophthalmitis

, MD, PhDORCID Icon, , MD, MAORCID Icon, , MD, MA, , MD, MA & , MD, MA
Pages 1386-1395 | Received 31 Jul 2022, Accepted 21 Nov 2022, Published online: 19 Dec 2022
 

ABSTRACT

Purpose

Exogenous endophthalmitis (ExE) results from microbial infection as a complication of ocular surgery, penetrating ocular trauma, and intraocular foreign bodies. We herein review the classification of ExE, etiological agents, differential diagnosis and therapeutic challenges.

Methods

Narrative Literature Review.

Results

Identification of the causative agent through ocular fluid analysis is central in the diagnostic work-up of ExE. Prompt intravitreal antimicrobial therapy is key to successful management of ExE and vitrectomy is essential in severe cases. In culture-negative cases, and in the presence of specific features, a diagnosis of sterile intraocular inflammation or toxic syndrome should be suspected.

Conclusion

Strict adherence to treatment guidelines may improve outcomes of ExE, however the ultimate prognosis, especially in severe cases, may depend more on the virulence of the causative organism and associated ocular complications. Accurate differential diagnosis and effective treatment are crucial elements in the management and prognosis of non-infectious masquerades of ExE.

Disclosure statement

Janet L. Davis declares the following interests: Data Safety Monitoring committees for 4D Molecular Therapeutics and Kodiak Biosciences. NIH grant support through subcontracts with Johns Hopkins University and the University of California San Francisco. Claudia Fabiani, Manisha Agarwal, Mohit Dogra and Gian Marco Tosi report no conflict of interest.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.